logo
HomeArticlesAbout
Register | Login
Review
Folia Medica 63(5): 637-646
https://doi.org/10.3897/folmed.63.e58995 (31 Oct 2021)
Other versions:
XML
PDF
 
 
Twitter
Facebook
Mendeley
Reddit
Notify a colleague
  • Article InfoArticle Info
  • CitationCitation
  • MetricsMetrics
  • CommentComment
  • RelatedRelated
  • CitedCited
Folia Medica 63(5): 637-646
doi: 10.3897/folmed.63.e58995
Received: 26 Sep 2020 | Approved: 01 Dec 2020 | Published: 31 Oct 2021
This article is part of:
Folia Medica 63(5)
Authors
Sandip N. Badeliya - Corresponding author
RK University, Rajkot, India
Articles by this author in:  CrossRef  |  PubMed  |  Google Scholar
Pankaj P. Kapupara
RK University, Rajkot, India
Articles by this author in:  CrossRef  |  PubMed  |  Google Scholar
Navneet F. Chauhan
Saraswati Institute of Pharmaceutical Sciences, Dhanap, India
Articles by this author in:  CrossRef  |  PubMed  |  Google Scholar
   
   
Ishan I. Panchal
Parul University, Vadodara, India
Articles by this author in:  CrossRef  |  PubMed  |  Google Scholar
Author contributions
Sandip Badeliya, Ishan Panchal, and Navneet Chauhan have done a review on the upcoming antimalarial drug candidates and prepared a detailed review note on that. Pankaj Kapupara has checked and edited this review article 
Conflict of interest
The authors have declared that no competing interests exist.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Powered by

This website uses cookies in order to improve your web experience. Read our Cookies Policy

OK